IBDEI1LT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26840,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,26841,0)
 ;;=N40.0^^132^1304^20
 ;;^UTILITY(U,$J,358.3,26841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26841,1,3,0)
 ;;=3^Enlarged Prostate w/o LUTS
 ;;^UTILITY(U,$J,358.3,26841,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,26841,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,26842,0)
 ;;=N40.1^^132^1304^19
 ;;^UTILITY(U,$J,358.3,26842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26842,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,26842,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,26842,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,26843,0)
 ;;=L03.811^^132^1304^10
 ;;^UTILITY(U,$J,358.3,26843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26843,1,3,0)
 ;;=3^Cellulitis,Head (Except Face)
 ;;^UTILITY(U,$J,358.3,26843,1,4,0)
 ;;=4^L03.811
 ;;^UTILITY(U,$J,358.3,26843,2)
 ;;=^5009063
 ;;^UTILITY(U,$J,358.3,26844,0)
 ;;=L03.818^^132^1304^11
 ;;^UTILITY(U,$J,358.3,26844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26844,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,26844,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,26844,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,26845,0)
 ;;=L03.891^^132^1304^35
 ;;^UTILITY(U,$J,358.3,26845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26845,1,3,0)
 ;;=3^Lymphangitis,Head (Except Face),Acute
 ;;^UTILITY(U,$J,358.3,26845,1,4,0)
 ;;=4^L03.891
 ;;^UTILITY(U,$J,358.3,26845,2)
 ;;=^5009065
 ;;^UTILITY(U,$J,358.3,26846,0)
 ;;=L03.898^^132^1304^36
 ;;^UTILITY(U,$J,358.3,26846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26846,1,3,0)
 ;;=3^Lymphangitis,Oth Sites,Acute
 ;;^UTILITY(U,$J,358.3,26846,1,4,0)
 ;;=4^L03.898
 ;;^UTILITY(U,$J,358.3,26846,2)
 ;;=^5009066
 ;;^UTILITY(U,$J,358.3,26847,0)
 ;;=L03.90^^132^1304^12
 ;;^UTILITY(U,$J,358.3,26847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26847,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,26847,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,26847,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,26848,0)
 ;;=L03.91^^132^1304^34
 ;;^UTILITY(U,$J,358.3,26848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26848,1,3,0)
 ;;=3^Lymphangitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,26848,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,26848,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,26849,0)
 ;;=M51.26^^132^1304^32
 ;;^UTILITY(U,$J,358.3,26849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26849,1,3,0)
 ;;=3^Intervertebral Disc Displacement,Lumbar Region
 ;;^UTILITY(U,$J,358.3,26849,1,4,0)
 ;;=4^M51.26
 ;;^UTILITY(U,$J,358.3,26849,2)
 ;;=^5012249
 ;;^UTILITY(U,$J,358.3,26850,0)
 ;;=M51.27^^132^1304^33
 ;;^UTILITY(U,$J,358.3,26850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26850,1,3,0)
 ;;=3^Intervertebral Disc Displacement,Lumbosacral Region
 ;;^UTILITY(U,$J,358.3,26850,1,4,0)
 ;;=4^M51.27
 ;;^UTILITY(U,$J,358.3,26850,2)
 ;;=^5012250
 ;;^UTILITY(U,$J,358.3,26851,0)
 ;;=G47.33^^132^1304^51
 ;;^UTILITY(U,$J,358.3,26851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26851,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,26851,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,26851,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,26852,0)
 ;;=G44.1^^132^1304^55
 ;;^UTILITY(U,$J,358.3,26852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26852,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,26852,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,26852,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,26853,0)
 ;;=R73.01^^132^1304^30
 ;;^UTILITY(U,$J,358.3,26853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26853,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,26853,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,26853,2)
 ;;=^5019561
